A nationwide study found insurers increasingly rejected first-time brand-name prescriptions, often because of formulary ...
CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...
A real-world report showed the safety and efficacy of zanubrutinib after a community oncology practice replaced ibrutinib with the newer Bruton tyrosine kinase inhibitor on its formulary. A bevy of ...
Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, ...
When you opt for a Medicare Part D plan with a low monthly premium, such as $0 or $10, you might think you're saving money. However, these plans often come with restrictive formularies. A formulary is ...
Your health insurance plan includes a list called a formulary -- a directory of the drugs it covers. If you've ever been stunned at how much it cost you to fill a prescription, it’s possible that ...
CVS Caremark will expand the use of lower-cost biosimilars across multiple therapeutic categories effective July 1. In addition to changes involving Stelara, CVS Caremark is expanding biosimilar ...
Over the past two decades the use of step therapy or edits by health insurers has increased significantly. Step therapy, also called step edits, implies that in a given therapeutic class lower cost ...
Just as Eli Lilly appeared to be gaining an edge over its metabolic medicine rival Novo Nordisk in the U.S. obesity market, Novo has locked in a new formulary access deal that could give its star ...
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
The PN said that cancer patients should receive the medicines they need through the public health service with dignity, ...